Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2

Known as: APVAC2 
A personalized peptide-based cancer vaccine comprised of one or two de novo synthesized patient-specific tumor-mutated peptides associated with… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Cancer immunotherapy to gliomas has so far failed to show encouraging results, as gliomas are rarely mutated and show various… (More)
Is this relevant?
2018
2018
Patients with glioblastoma currently do not sufficiently benefit from recent breakthroughs in cancer treatment that use… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2016
2016
The Glioma Actively Personalized Vaccine Consortium (GAPVAC; funded by the European Union Framework 7 Program) aims at treating… (More)
Is this relevant?